Cargando…
Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer
In the field of drug repurposing, the use of statins for treating dyslipidemia is considered promising in ovarian cancer treatment based on epidemiological studies and basic research findings. Biomarkers should be established to identify patients who will respond to statin treatment to achieve clini...
Autores principales: | Kobayashi, Yusuke, Takeda, Takashi, Kunitomi, Haruko, Chiwaki, Fumiko, Komatsu, Masayuki, Nagai, Shimpei, Nogami, Yuya, Tsuji, Kosuke, Masuda, Kenta, Ogiwara, Hideaki, Sasaki, Hiroki, Banno, Kouji, Aoki, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880614/ https://www.ncbi.nlm.nih.gov/pubmed/35215239 http://dx.doi.org/10.3390/ph15020124 |
Ejemplares similares
-
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2018) -
Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2017) -
Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology
por: Nogami, Yuya, et al.
Publicado: (2019) -
Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015) -
Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins
por: Takeda, Takashi, et al.
Publicado: (2019)